Vanguard Group Inc. Sells 75,748 Shares of Addus HomeCare Corporation $ADUS

Key Points

• Vanguard Group Inc. has reduced its stake in Addus HomeCare Corporation by 5.4%, selling 75,748 shares, bringing its total ownership to approximately 7.27% of the company valued at $132.24 million.
• Other institutional investors have been active, with Barclays PLC increasing its holdings by 43.9% and First Trust Advisors LP raising theirs by 108.5% during the fourth quarter.
• Addus HomeCare's stock has an average price target of $138.63 according to analysts, with a notable rating shift from "hold" to "buy" by Wall Street Zen.

Vanguard Group Inc. trimmed its stake in Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) by 5.4% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,337,233 shares of the company's stock after selling 75,748 shares during the period. Vanguard Group Inc. owned about 7.27% of Addus HomeCare worth $132,239,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of ADUS. GAMMA Investing LLC increased its holdings in Addus HomeCare by 10,307.8% in the first quarter. GAMMA Investing LLC now owns 130,930 shares of the company's stock valued at $12,948,000 after purchasing an additional 129,672 shares during the period. Bank of America Corp DE increased its holdings in Addus HomeCare by 273.6% in the fourth quarter. Bank of America Corp DE now owns 175,070 shares of the company's stock valued at $21,945,000 after purchasing an additional 128,211 shares during the period. Allianz Asset Management GmbH increased its holdings in Addus HomeCare by 1,229.4% in the first quarter. Allianz Asset Management GmbH now owns 100,898 shares of the company's stock valued at $9,978,000 after purchasing an additional 93,308 shares during the period. Principal Financial Group Inc. increased its holdings in Addus HomeCare by 18.3% in the first quarter. Principal Financial Group Inc. now owns 475,818 shares of the company's stock valued at $47,054,000 after purchasing an additional 73,720 shares during the period. Finally, Raymond James Financial Inc. acquired a new stake in Addus HomeCare in the fourth quarter valued at $6,637,000. 95.35% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Addus HomeCare

In related news, Director Veronica Hill-Milbourne sold 1,571 shares of the firm's stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $114.93, for a total value of $180,555.03. Following the transaction, the director owned 5,067 shares of the company's stock, valued at approximately $582,350.31. This trade represents a 23.67% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Brian Poff sold 7,739 shares of the firm's stock in a transaction dated Monday, August 25th. The shares were sold at an average price of $116.82, for a total transaction of $904,069.98. Following the completion of the transaction, the executive vice president directly owned 56,980 shares in the company, valued at approximately $6,656,403.60. The trade was a 11.96% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 34,310 shares of company stock valued at $3,958,375 in the last 90 days. 4.50% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of analysts have weighed in on the company. Royal Bank Of Canada increased their price target on Addus HomeCare from $133.00 to $134.00 and gave the stock an "outperform" rating in a report on Friday, August 22nd. Barclays increased their price target on Addus HomeCare from $83.00 to $109.00 and gave the stock an "underweight" rating in a report on Tuesday, August 19th. TD Cowen increased their price target on Addus HomeCare from $135.00 to $139.00 and gave the stock a "buy" rating in a report on Wednesday, August 6th. JMP Securities reiterated a "market outperform" rating and set a $150.00 price target on shares of Addus HomeCare in a report on Wednesday, July 16th. Finally, Wall Street Zen upgraded Addus HomeCare from a "hold" rating to a "buy" rating in a report on Sunday, June 29th. Two investment analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Buy" and an average target price of $138.38.

Addus HomeCare Stock Up 1.2%

Shares of ADUS stock traded up $1.35 on Wednesday, reaching $115.50. 121,663 shares of the company were exchanged, compared to its average volume of 201,508. The company has a market cap of $2.13 billion, a price-to-earnings ratio of 25.50, a PEG ratio of 1.74 and a beta of 0.80. The company has a 50-day moving average of $112.03 and a 200-day moving average of $107.01. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.74 and a quick ratio of 1.74. Addus HomeCare Corporation has a one year low of $88.96 and a one year high of $136.72.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last released its quarterly earnings data on Monday, August 4th. The company reported $1.49 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.45 by $0.04. The company had revenue of $349.44 million for the quarter, compared to analysts' expectations of $345.71 million. Addus HomeCare had a net margin of 6.51% and a return on equity of 9.39%. The business's revenue was up 21.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.35 EPS. Analysts anticipate that Addus HomeCare Corporation will post 4.59 earnings per share for the current year.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.